InsidersTradesSigma
CellaVision AB Stock: price and management transactions · Finland · FIN-FSA
Follow the CellaVision AB share price and the full directors' dealings record of the company, a listed issuer based in Finland. Shares are quoted on FI FI, under the authority of FIN-FSA. Operating in the Health Care sector, CellaVision AB has published 11 insider filings. Market capitalisation: €3.5bn. The latest transaction was filed on 12 June 2026 (Purchase). Among the most active insiders: christer Fåhraeus. All data is accessible without an account.
11
Insider Decl.
0
Thresholds
€2m
10 ops.
Buy Volume
·
0 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate CellaVision AB Strong Buy (bullish), based on 4 analysts. Average price target: SEK 177.75.
22Σ signal
Fundamental score
Ranked 4,017 of 25,921 companies
69.6
score / 100
Value54
Quality85
FCF yld3.6%
Earn yld4.8%
EV/EBITDA13.8x
ROE15%
Gross mgn68%
Net mgn20%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 12 June 2026
Declarations11 total
760 shares@ SEK 137.880.0003% mcap100.0% of flowAktieFI:csv-af2d56b96db0a51e618e
Ideal exit: 9 Mar 2027 (T+270)
62,000 shares@ SEK 127.400.024% mcap49.4% of flowAktieFI:csv-83b8a1f39bbd96d0fbcc
Ideal exit: 5 Mar 2027 (T+270)
30,000 shares@ SEK 129.100.012% mcap24.2% of flowAktieFI:csv-b8ccc920a00eb37ef8f0
Ideal exit: 5 Mar 2027 (T+270)
33,000 shares@ SEK 127.600.013% mcap26.4% of flowAktieFI:csv-807fa0613b87adb1f094
Ideal exit: 6 Mar 2027 (T+270)
●
Arbetstagarrepresentant i styrelsen eller arbetstagarsuppleantExecutives
314 shares@ SEK 127.000.0001% mcap50.0% of flowAktieFI:csv-e093630f5b8b9e29b1f5
Ideal exit: 6 Mar 2027 (T+270)
●
Arbetstagarrepresentant i styrelsen eller arbetstagarsuppleantExecutives
314 shares@ SEK 127.000.0001% mcap100.0% of flowAktieFI:A003Z785-1
Ideal exit: 6 Mar 2027 (T+270)
●
Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutives
10,000 shares@ SEK 127.000.0038% mcap50.0% of flowAktieFI:csv-15c7c08d7f6f4d796b4f
Ideal exit: 5 Mar 2027 (T+270)
●
Annan medlem i bolagets administrations-, lednings- eller kontrollorganExecutives
10,000 shares@ SEK 127.000.0039% mcap100.0% of flowAktieFI:A003Z721-1
Ideal exit: 5 Mar 2027 (T+270)
76,434 shares0AktieFI:A003X896-1
20,000 shares@ €11.35920.0078% mcap50.0% of flowAktieFI:A003X894-1
Ideal exit: 22 Jan 2027 (T+270)
20,000 shares@ €11.36980.0078% mcap50.0% of flowAktieFI:A003X901-1
Ideal exit: 19 Jan 2027 (T+270)
11 of 11 declarations
About CellaVision AB
CellaVision AB is a company focused on developing image analysis solutions for medical diagnostics. It is listed on the Stockholm Stock Exchange (XSTO).